Gerresheimer AG (GXI) Given a €65.00 Price Target by Kepler Capital Markets Analysts

Gerresheimer AG (ETR:GXI) has been given a €65.00 ($76.47) target price by analysts at Kepler Capital Markets in a research note issued on Friday. The firm currently has a “sell” rating on the stock. Kepler Capital Markets’ target price would suggest a potential downside of 1.60% from the company’s current price.

A number of other brokerages also recently commented on GXI. Independent Research GmbH set a €68.00 ($80.00) price objective on Gerresheimer AG and gave the stock a “neutral” rating in a research note on Tuesday, September 5th. Deutsche Bank AG set a €62.00 ($72.94) price objective on Gerresheimer AG and gave the stock a “neutral” rating in a research note on Tuesday, September 5th. Berenberg Bank set a €75.00 ($88.24) price target on Gerresheimer AG and gave the stock a “buy” rating in a research note on Monday, September 4th. J P Morgan Chase & Co set a €99.40 ($116.94) price target on Gerresheimer AG and gave the stock a “buy” rating in a research note on Thursday, August 31st. Finally, DZ Bank AG reissued a “buy” rating on shares of Gerresheimer AG in a research note on Monday, July 17th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of €72.64 ($85.46).

Gerresheimer AG (ETR:GXI) opened at €66.06 ($77.72) on Friday.

COPYRIGHT VIOLATION NOTICE: This story was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://sportsperspectives.com/2017/11/05/gerresheimer-ag-gxi-given-a-65-00-price-target-by-kepler-capital-markets-analysts.html.

About Gerresheimer AG

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply